Compare Chubb Ltd (CB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chubb Ltd vs State Street SPDR S&P Biotech ETF — how do they compare? Chubb Ltd trades at $345.1 (market cap $133.90B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: Chubb Ltd pays a 1.18% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Chubb Ltd nearer its low. Which is the better fit depends on your goals.
| CB | XBI | |
|---|---|---|
Market Cap | $133.90B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $363.50 | $164.28 |
52-Week Low | $268.20 | $86.92 |
Enterprise Value | $154.74B | — |
Dividend Yield | 1.18% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Chubb Ltd
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
Read more on CB →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
